June 3, 2009 – UltraSPECT said yesterday it will launch its Attenuation Correction/Scatter Correction (ACSC) package to its nuclear medicine image reconstruction products following the FDA clearance of the software package.
The new ACSC package is a field upgrade option for WBR cardiac image reconstruction products used in conjunction with gamma camera systems with access to CT-generated attenuation maps. WBR products enhanced from the ACSC upgrade option are UltraSPECT’s Xpress.Cardiac and Xpress3.Cardiac, which enable half-time and quarter-time acquisitions, respectively.
The company said ongoing trends in nuclear imaging indicate growth in hybrid SPECT/CT imaging, and hence, greater access to attenuation maps. The ACSC package was developed for WBR image reconstruction using either the Xpress.Cardiac or the Xpress3.Cardiac product. The company said the benefits include higher diagnostic accuracy and increased interpretive certainty.
UltraSPECT’s ACSC package, along with UltraSPECT’s Xpress.Cardiac, Xpress3.Cardiac, and Xpress/Xact.Bone products, are distributed in the USA exclusively by Cardinal Health.
The company plans to launch the new product at the Society of Nuclear Medicine annual meeting June 13-17 in Toronto, Canada.
For more information: www.cardinalhealth.com, www.ultraspect.com
July 30, 2024 
